In the inaugural event of the Global Cancer Movement, initiated by OncoDaily, Dr. Christine Parseghian, GI Medical Oncology Professor at MD Anderson Cancer Center, explored the evolving landscape of EGFR-targeted therapy resistance and re-challenge strategies in colorectal cancer. Held virtually, this session provided key insights into overcoming treatment resistance and optimizing patient outcomes.
